These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36866090)

  • 1. Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies.
    Perelló M; Rio-Aige K; Rius P; Bagaría G; Jambrina AM; Gironès M; Pérez-Cano FJ; Rabanal M
    Front Public Health; 2023; 11():1116337. PubMed ID: 36866090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Medicine Abuse Trends in Community Pharmacies: The Medicine Abuse Observatory (MAO) in a Region of Southern Europe.
    Perelló M; Rio-Aige K; Guayta-Escolies R; Gascón P; Rius P; Jambrina AM; Bagaria G; Armelles M; Pérez-Cano FJ; Rabanal M
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 Pandemic on the Greek population: Suicidal ideation during the first and second lockdown.
    Gournellis R; Efstathiou V
    Psychiatriki; 2021 Dec; 32(4):267-270. PubMed ID: 34860683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abuse and Misuse of Prescription and Nonprescription Drugs from Community Pharmacies in Aden City-Yemen.
    Abood EA; Wazaify M
    Subst Use Misuse; 2016 Jun; 51(7):942-7. PubMed ID: 27100671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
    Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
    Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States.
    de Dios C; Fernandes BS; Whalen K; Bandewar S; Suchting R; Weaver MF; Selvaraj S
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109176. PubMed ID: 34808468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Pharmacist as Gatekeeper of Prescription Drug Abuse: Return to "Community Scientists"].
    Shimane T
    Yakugaku Zasshi; 2016; 136(1):79-87. PubMed ID: 26725672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in France.
    Orriols L; Gaillard J; Lapeyre-Mestre M; Roussin A
    Drug Saf; 2009; 32(10):859-73. PubMed ID: 19722729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic preparedness of community pharmacies for COVID-19.
    Bahlol M; Dewey RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1888-1896. PubMed ID: 32417070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 pandemic on dispensing medicines in the community pharmacy.
    Al-Azzawi S; Masheta D
    Int J Risk Saf Med; 2023; 34(4):295-311. PubMed ID: 37355915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the frequency and pattern of drugs detected among suspected drug users during the COVID-19 pandemic in Turkey.
    Öztürk YE; Yeter O; Ateş I
    Int J Legal Med; 2022 Sep; 136(5):1273-1279. PubMed ID: 35147732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic Drug Prescription in Nursing Homes During the COVID-19 Pandemic.
    Ferro Uriguen A; Laso Lucas E; Sannino Menicucci C; Iturrioz Arrechea I; Alaba Trueba J; Echevarría Orella E; Gil Goikouria J; Beobide Telleria I
    Drugs Aging; 2022 Jun; 39(6):467-475. PubMed ID: 35726042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.
    Niles JK; Gudin J; Radcliff J; Kaufman HW
    Popul Health Manag; 2021 Feb; 24(S1):S43-S51. PubMed ID: 33031013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship between Customers and Community Pharmacies during the COVID-19 (SARS-CoV-2) Pandemic: A Survey from Italy.
    Baratta F; Ciccolella M; Brusa P
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
    Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
    Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.